Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 80 | −1 |
| Shares | 36.4M | 113 | 34.9M | −1.56M (−4.3%) |
| Value | $762.1M | $2.00K | $512.1M | −$250.0M (−32.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 1,000,199 | $14.7M | 0.02% |
| Regents of the University of California | 148,322 | $2.18M | 0.31% |
| Price T Rowe Associates Inc | 47,769 | $702.0K | 0.00% |
| PDT Partners, LLC | 33,057 | $486.0K | 0.04% |
| Renaissance Technologies LLC | 26,300 | $387.0K | 0.00% |
| Gsa Capital Partners LLP | 23,954 | $352.0K | 0.04% |
| Jasper Ridge Partners, L.P. | 20,870 | $307.0K | 0.01% |
| Corton Capital Inc. | 16,912 | $249.0K | 0.11% |
| Ensign Peak Advisors, Inc | 10,360 | $152.0K | 0.00% |
| Macquarie Group Ltd | 354 | $5.00K | 0.00% |
| Ellevest, Inc. | 8 | $0 | 0.00% |
Sold out (12)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Emerald Mutual Fund Advisers Trust | 742,666 | $15.5M |
| Emerald Advisers, LLC | 726,236 | $15.2M |
| Eventide Asset Management, LLC | 724,972 | $15.2M |
| Point72 Asset Management, L.P. | 333,782 | $6.98M |
| Alyeska Investment Group, L.P. | 109,945 | $2.30M |
| Citadel Advisors LLC | 15,377 | $322.0K |
| DekaBank Deutsche Girozentrale | 10,500 | $215.0K |
| Nisa Investment Advisors, LLC | 3,350 | $70.0K |
| Quantbot Technologies LP | 2,700 | $56.0K |
| Cubist Systematic Strategies, LLC | 2,145 | $45.0K |
| Penserra Capital Management LLC | 900 | $18.0K |
| Simplex Trading, LLC | 116 | $2.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 113 | $2.00K |